Processa Pharmaceuticals Names Russell L. Skibsted as Chief Financial Officer
17 juil. 2024 08h00 HE
|
Processa Pharmaceuticals, Inc.
HANOVER, Md., July 17, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (Processa or the Company), a clinical-stage pharmaceutical company focused on developing the next...